Serum immunoglobulin and soluble IL-2 receptor levels in small intestinal overgrowth with indigenous gut flora

Digestive Diseases and Sciences

Volumn 44, Issue 5, 1999, Pages 939-944

  Riordan, Stephen M ^a   McIver, Christopher J ^b   Wakefield, Denis ^b   Thomas, Mervyn C ^b   Duncombe, Vic M ^b   Bolin, Terry D ^b  

^a UNIVERSITY COLLEGE LONDON   (United Kingdom)

^b NONE

Author keywords

Bacterial overgrowth; Indigenous gut flora; Systemic immunity

Indexed keywords

IMMUNOGLOBULIN G3; IMMUNOGLOBULIN SUBCLASS; INTERLEUKIN 2 RECEPTOR;

ADULT; AGED; ARTICLE; BACTERIAL FLORA; BACTERIAL OVERGROWTH; CELL COUNT; CLINICAL ARTICLE; CONTROLLED STUDY; HUMAN; IMMUNE RESPONSE; IMMUNITY; INTESTINE FLORA; LAMINA PROPRIA; PRIORITY JOURNAL; SMALL INTESTINE;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; HUMANS; IMMUNOGLOBULIN A; IMMUNOGLOBULIN G; IMMUNOGLOBULINS; INTESTINE, SMALL; MIDDLE AGED; RECEPTORS, INTERLEUKIN-2;

EID: 0032959002     PISSN: 01632116     EISSN: None     Source Type: Journal    
DOI: 10.1023/A:1026652412554     Document Type: Article

References (33)

1. Weiner HL, Friedman A, Miller A, Khoury SJ, Al-Sabbagh A, Santos L, Sayrgh M, Nussenblatt RB, Trentham DE, Hafler DA: Oral tolerance: Immunologic mechanisms and treatment of animal and human organ-specific autoimmune diseases by oral administration of autoantigens. Annu Rev Immunol 12:809-837, 1994
2. Hacney MR: Immune disorders of the gastrointestinal tract. In DJ Weatherall, JGG Ledingham, DA Warrell (eds). Oxford Textbook of Medicine, 3rd ed. Oxford, Oxford University Press, 1996, pp 1836-1845
3. McIamed D, Friedman A: Direct evidence for anergy in T lymphocytes tolerized by oral administration of ovalbumin. Eur J Immunol 23:935-942, 1993
4. Miller A, Lider O, Roberts AB, Sporn M, Weiner HL: Suppressor T cells generated by oral tolerization to myelin basic protein suppress both in vitro and in vivo immune responses by the release of TGF-β following antigen-specific triggering. Proc Natl Acad Sci USA 89:421-425, 1992
5. Wannemuchler MJ, Kiyono H, Babb LJ, Michalek SM, McGhee JR: Lipopolysaccharide (LPS) regulation of the immune response: LPS converts germfree mice to sensitivity to oral tolerance induction. J Immunol 129:959-965, 1982
6. Sudo N, Sawamura S, Tanaki K, Aiba Y, Kubo C, Koga Y: The requirement of intestinal bacterial flora for the development of an IgE production system fully susceptible to oral tolerance induction. J Immunol 159:1739-1745, 1997
7. Riordan SM, McIver CJ, Wakefield D, Duncombe VM, Bolin TD, Thomas MC: Luminal immunity in small intestinal bacterial overgrowth and old age. Scand J Gastroenterol 31:1103-1109, 1996
8. Kitam A, Strober W: Regulation of Cγ subclass germ-line transcripts in human peripheral blood B cells. J Immunol 151:3478-3488, 1993
9. Fujieda S, Zhang J, Saxon A: IL-4 plus CD40 monoclonal antibody induces human B cells gamma subclass-specific isotype switch: Switching to gamma 1, gamma 3, and gamma 4, but not gamma 2. J Immunol 155:2318-2328, 1995
10. Takatsu K, Tominaga A, Harada N, Mita S, Matsumoto M, Takahashi T, Kikuchi Y, Yamaguchi N: T cell-replacing factor (TRF)/interleukin 5 (IL-5): Molecular and functional properties. Immunol Rev 102:107-135, 1988
11. McGhee JR, Beagley KW, Eldridge JH, Fujihashi K, Luc C, Moldoveanu Z, Mestecky J, Radl J, Kiyono H: Interleukin cascade for the regulation of IgA synthesis and immune responses. Protides Biol Fluids 36:183-191, 1989
12. Rubin LA, Kurman CC, Fritz ME, Biddison WE, Boutin B, Yarchoan R, Nelson DL: Soluble interleukin 2 receptors are released from activated human lymphoid cells in vitro. J Immunol 135:3172-3177, 1985
13. Felser JM, Raff MJ: Infectious diseases and aging: Immunologic perspectives. JAGS 31:802-807, 1983
14. Thoman ML, Weigle WO: The cellular and subcellular basis of immunosenescence. Adv Immunol 46:221-261, 1989
15. Simon GL, Gorbach SL: The human intestinal microflora. Dig Dis Sci 31(suppl):147-162, 1986
16. Kirsch G: Bacterial overgrowth. Am J Gastroenterol 85:231-237, 1990
17. Haboubi NY, Montgomery RD: Small-bowel bacterial overgrowth in elderly people: Clinical significance and response to treatment. Age Ageing 21:13-19, 1992
18. Cowan ST: Cowan & Steel's Manual for the Identification of Medical Bacteria, 2nd ed. Cambridge, Cambridge University Press, 1979
19. 14C-D-xylose breath test for detecting bacterial overgrowth in gastrointestinal motility disorders. Scand J Gastroenterol 28:963-968, 1993
20. Riordan SM, McIver CJ, Wakefield D, Duncombe VM, Bolin TD, Thomas MC: Luminal antigliadin antibodies in small intestinal bacterial overgrowth. Am J Gastroenterol 92:1335-1338, 1997
21. Arranz E, O'Mahony S, Barton JR, Ferguson A: Immunosenescence and mucosal immunity: Significant effects of old age on secretory IgA concentrations and intraepithelial lymphocyte counts. Gut 33:882-886, 1992
22. Cockroft DW, Gault MH. Prediction of creatinine clearance from serum creatinine. Nephron 16:31-41, 1976
23. Rubin LA, Nelson DL: The soluble interleukin-2 receptor: Biology, function and clinical application. Ann Intern Med 113:619-627, 1990
24. Skvaril F: IgG subclasses in viral infections. Monogr Allergy 19:134-143, 1986
25. Richman LK, Graeff AS, Yarchoan R, Strober W: Simultaneous induction of antigen-specific IgA helper T cells and IgG suppressor T cells in murine Peyer's patch after protein feeding. J Immunol 126:2079-2083, 1981
26. Cummins AG, Pentilla IA, LaBrooy JT, Robb TA, Davidson GP: Recovery of the small intestine in coeliac disease on a gluten-free diet; Changes in intestinal permeability, small bowel morphology and T-cell activity. J Gastroenterol Hepatol 6:53-57, 1991
27. Dalekos GN, Manoussakis MN, Goussia AC, Tsianos EV, Moustopoulos HM: Soluble interleukin-2 receptors, antineutrophil cytoplasmic antibodies and other autoantibodies in patients with ulcerative colitis. Gut 34:658-664, 1993
28. Bruggemann M, Williams GT, Bindon CI, Clark MR, Walker MR, Jefferis R, Waldmann H, Neuberger MS: Comparison of the effector functions of human immunoglobulins using a matched set of chimeric antibodies. J Exp Med 166:1351-1361, 1987
29. Oxelius VA, Hanson LA, Bjorkander J, Hammastrom L, Sjoholm A: IgG3 deficiency: Common in obstructive lung disease. Monogr Allergy 20:106-115, 1986
30. Hammarstrom L, Smith CIE: Critical aspects on diagnosing IgG subclass deficiency and its clinical consequence. Protides Biol Fluids 36:133-138, 1989
31. Jefferis R, Kumararatne DS: Selective IgG subclass deficiency: Quantitation and clinical relevance. Clin Exp Immunol 81:357-367, 1990
32. Snowden JA, Milford-Ward A, Cookson LJ, McKendrick MW: Recurrent lymphocytic meningitis associated with isolated IgG subclass 3 deficiency. J Infect 27:285-289, 1993
33. Snowden JA, Milford-Ward A, Reilly JT: Symptomatic IgG3 deficiency successfully treated with intravenous immunoglobulin therapy. Postgrad Med J 70:924-926, 1994